Subscribe To
Amerigo resources ltd (arref) q3 2023 earnings call transcript
Amerigo Resources Ltd (OTCQX:ARREF) Q3 2023 Earnings Conference Call November 2, 2023 2:00 PM ET Company Participants Graham Farrell - Investor Relati...
November 4, 2023, 1:24 am
Rosen, a globally recognized law firm, encourages waldencast plc investors to inquire about securities class action investigation – wald, waldw
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...
November 4, 2023, 1:08 am
Docgo alert: bragar eagel & squire, p.c. reminds investors that a class action lawsuit has been filed against docgo, inc. and encourages investors to contact the firm
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that ...
November 4, 2023, 1:00 am
What happens to bitcoin price if spot etf isn’t approved?
It’s not surprising that analysts expect to see negative short-term price action if a bitcoin spot ET...
November 4, 2023, 12:59 am
Xrp news: sec v ripple recap as the november 9 countdown begins
Amid the SEC v Ripple lawsuit, Bill Hinman’s role and the Programmatic Sales ruling could take center...
November 4, 2023, 12:58 am
Latest bitcoin price data suggests double top above $200k in 2025 – cointelegraph
Bitcoin halving cycles still dictate potential BTC price highs and lows, DecenTrader co-founder Filbfilb says, as he doubles down on $180,000 in 2025....
November 4, 2023, 12:44 am
Fairfax financial: q3 2023 results indicate banner year ahead
YTD book value per share increased 16.4% before dividends and 15% ex-dividends. YTD gross premiums written up 7.5% with a combined ratio of ~94%. Mana...
November 4, 2023, 12:42 am
Weekly economic & financial commentary: q4 appears off to a slower start
summary United States: Q4 Appears Off to a Slower Start This week delivered an onslaught of economic in...
November 4, 2023, 12:38 am
Canadian imports softening on lower consumer and business spending
The week ahead will be a lighter one for data releases after signs of decelerating Canadian GDP growth, a higher unemployment rate in both the U.S. an...
November 4, 2023, 12:31 am
Investors sue barclays for inaccurately disclosing ex-ceo’s ties to jeffrey epstein – hagens berman
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Barclays PLC (BCS) Investors with substantial Losse...
November 4, 2023, 12:22 am
U.s. ipo weekly recap: biotech lexeo stumbles after $100 million ipo
Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar ...
November 4, 2023, 12:21 am
Otlk investor alert: robbins geller rudman & dowd llp announces that outlook therapeutics, inc. investors with substantial losses have opportunity to lead the outlook therapeutics class action lawsuit
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that the Outlook Therapeutics class action law...
November 4, 2023, 12:13 am
Canon isn't picture-perfect
Canon has operational advantages in its printing segment and has a strong global presence in various markets. However, the company's financial metrics...
November 4, 2023, 12:12 am
summary 11/6 – 11/10
Monday, Nov 6, 2023 Tuesday, Nov 7, 2023 Wednesday, Nov 8, 2023 Thursday, Nov 9, 2023 Friday, Nov 10, 2023 The post ...
November 4, 2023, 12:00 am
Egain corporation (egan) q1 2024 earnings call transcript
eGain Corporation (NASDAQ:EGAN ) Q1 2024 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Jim Byers - MKR IR Ashu Roy - CEO E...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Correction: national youth prevention summit highlights colorado campaign to protect teens from fentanyl
This release has been corrected to identify the source as SE2 Denver, Colo., Nov. 03, 2023 (GLOBE NEWSWIRE) — A national youth prevention ...
November 3, 2023, 11:10 pm